ASCO Leukemia Annual Meetingv3


ELEVATE-RR: Acalabrutinib demonstrates similar efficacy and better safety compared with ibrutinib

Converting PBMCs from CLL Patients Into Potent Tumor Killing Immune Cells

Pandemic Lessons: Is There a Role for Remote Patient Monitoring in Clinical Oncology?

Palliative Care And Coping In Patients With AML

ELEVATE-TN: long-term efficacy in chronic lymphocytic leukemia

Oncologists Underestimate Patient Use of Complementary Medicine